New York Academy Of Sciences

COLLABORATIVE RESEARCH: SUNY/NYAS STEM MENTORING PROGRAM STATEWIDE SCALE UP PROJECT

BEHAVIORAL EPIGENETICS

DISEASE DRIVERS OF AGING

ANIMAL MODELS AND DRUG DISCOVERY

PROBIOTICS, PREBIOTICS, AND THE HOST MICROBIOME: THE SCIENCE OF TRANSLATION

12TH INTERNATIONAL CONFERENCE ON MYASTHENIA GRAVIS AND RELATED DISORDERS

HYPOXIA AND CONSEQUENCES: FROM MOLECULE TO MALADY

BUILDING BETTER BRAINS: NEURAL PROSTHETICS AND BEYOND

FOURTH INTERNATIONAL CONFERENCE ON OXIDATIVE AND NITROSATIVE STRESS IN DISEASE

SIXTH ANNUAL ASPEN BRAIN FORUM: THE ADDICTED BRAIN AND NEW TREATMENT FRONTIERS

TENTH COOLEY'S ANEMIA SYMPOSIUM: BASIC SCIENCE, CLINICAL RESEARCH, AND PATIENT HEALTHCARE FOR THALASSEMIA SYNDROMES.

INAUGURAL CONFERENCE ON INTEGRATIVE PHYSIOLOGY

CONFERENCE: VALUES AND EMPATHY ACROSS SOCIAL BARRIERS: A NEUROCOGNITIVE APPROACH TO FAIRNESS

THE BONE MARROW NICHE AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS AND ENVIRONMENT

13TH INTERNATIONAL CONFERENCE ON MYASTHENIA GRAVIS AND RELATED DISORDERS

ALZHEIMER'S DISEASE VIEWED AS A NEUROVASCULAR INFLAMMATORY DISORDER

THROMBOLYSIS AND ACUTE STROKE TREATMENT (TAST) 2011: FORWARD TO ACUTE STROKE TRE

TOWARDS PERSONALIZED CANCER MEDICINE

CONFERENCE ON SHAPING THE DEVELOPING BRAIN: PRENATAL THROUGH EARLY CHILDHOOD

THE COGNITIVE NEUROSCIENCE OF LEARNING: IMPLICATIONS FOR EDUCATION

FETAL PROGRAMMING AND ENVIRONMENTAL EXPOSURES: IMPLICATIONS FOR PRENATAL CARE AND

MUSIC, SCIENCE & MEDICINE: FRONTIERS IN BIOMEDICAL RESEARCH & CLINICAL APPLICATIO

CONFERENCE GRANT ENTITLED-SYNTHETIC BIOLOGY APPROACHES TO IMPROVE HUMAN AND ENVIRONMENTAL HEALTH.

ELEVENTH COOLEY'S ANEMIA SYMPOSIUM - ELEVENTH COOLEY’S ANEMIA SYMPOSIUM PROJECT SUMMARY THALASSEMIA SYNDROMES AFFECT AT LEAST TWO MILLION PEOPLE WORLDWIDE, AND RESEARCHERS BELIEVE THAT SEVERAL HUNDRED MILLION PEOPLE MAY BE “SILENT CARRIERS” OF A THALASSEMIA TRAIT, MAKING IT ONE OF THE MOST COMMON SINGLE- GENE DISORDERS IN HUMANS. THE ELEVENTH COOLEY'S ANEMIA SYMPOSIUM, WHICH WILL BE HELD THE CURE IN NEW YORK CITY, NY, USA ON OCTOBER 17–20, 2022, REPRESENTS THE LARGEST GLOBAL GATHERING OF THALASSEMIA EXPERTS, AND PROVIDES ONE OF THE FEW INSTANCES EACH DECADE THAT THE INTERNATIONAL RESEARCH COMMUNITY, THE PHARMACEUTICAL INDUSTRY, AND FUNDING AGENCIES DEDICATED TO FIGHTING THIS BLOOD DISORDER COME TOGETHER. THIS 3.5- DAY CONFERENCE WILL CONVENE APPROXIMATELY 250 ATTENDEES, INCLUDING SCIENTIFIC RESEARCHERS WORKING IN THE FIELDS OF MOLECULAR AND CELLULAR BIOLOGY, GENE THERAPY, AND STEM CELL DEVELOPMENT, AS WELL AS CLINICAL SPECIALISTS FROM THE FIELDS OF HEMATOLOGY, STEM CELL TRANSPLANTATION, MATERNAL-FETAL HEALTH, TRANSFUSION MEDICINE, AND PEDIATRICS, AMONG OTHERS. THE MAIN OBJECTIVES OF THIS CONFERENCE ARE TO: (I) PROVIDE A NEUTRAL FORUM FOR DISCUSSION OF EXISTING CLINICAL DATA, EMERGING STRATEGIES, AND FUTURE DIRECTIONS FOR RESEARCH AND TREATMENT OF GENETIC HEMOGLOBINOPATHIES, INCLUDING COOLEY’S ANEMIA; (II) ATTRACT/SHOWCASE EARLY CAREER AND UNDERREPRESENTED INVESTIGATORS (INCLUDING WOMEN, ETHNIC/RACIAL MINORITIES, AND PERSONS WITH DISABILITIES) VIA SHORT TALKS, POSTERS, TRAVEL FELLOWSHIPS, AND TO PROVIDE OPPORTUNITIES TO INTERACT WITH SENIOR INVESTIGATORS; (III) DISSEMINATE THE CONFERENCE PROCEEDINGS TO THE INTERNATIONAL COMMUNITY; AND (IV) FOSTER COLLABORATION BETWEEN ACADEMIA, MEDICINE, INDUSTRY, AND GOVERNMENT TO PROMOTE KNOWLEDGE EXCHANGE AND SUCCESSFUL TRANSLATION OF RESEARCH INTO IMPROVED DIAGNOSTICS AND PATIENT THERAPIES FOR THALASSEMIA AND TREATMENT-RELATED ORGAN DAMAGE. CUTTING- EDGE TOPICS TO BE DISCUSSED DURING THIS SYMPOSIUM INCLUDE GLOBIN GENE REGULATION, IRON METABOLISM, MANAGEMENT OF CLINICAL COMPLICATIONS OF THALASSEMIA INCLUDING A FOCUS ON ALPHA THALASSEMIA, A MAJOR GLOBAL HEALTH PROBLEM, ASSESSMENT AND TREATMENT OF IRON OVERLOAD, RESULTS OF ONGOING CLINICAL TRIALS OF GENE THERAPY, HEMATOPOIETIC STEM CELL TRANSPLANTATION, AND NOVEL DRUGS, AS WELL AS INNOVATIVE APPROACHES TO GENE THERAPY. THE GOALS OF THIS SYMPOSIUM STRONGLY SUPPORT THE MISSION OF THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE AND NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES IN THAT THE MEETING WILL FOCUS ON MULTIPLE PRIORITY AREAS OF NEED: TO ADVANCE HEMATOLOGY RESEARCH, TREATMENT AND CURE OF DISORDERS OF HEMOGLOBIN, AND TO IMPROVE SAFETY AND EFFICACY IN BLOOD TRANSFUSION MEDICINE — INCLUDING THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF IRON OVERLOAD AND SUBSEQUENT DAMAGE TO THE LIVER, HEART, AND ENDOCRINE SYSTEM. DISCUSSIONS ORIGINATING FROM THE CONFERENCE, AND THEIR DISSEMINATION VIA PUBLICATION IN ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, WILL HAVE GLOBAL IMPACT BY IMPROVING SCIENTIFIC UNDERSTANDING, ADVANCING BREAKTHROUGH THERAPIES, AND ULTIMATELY REDUCING THE HEALTHCARE BURDEN OF THIS FAMILY OF GENETIC BLOOD DISORDERS.

NINTH COOLEY'S ANEMIA SYMPOSIUM

DIABETIC KIDNEY DISEASE: DRUG DISCOVERY AND CLINICAL DEVELOPMENT CHALLENGES

CELL AND MOLECULAR BIOLOGY: CHROMOSOMES CANCER AND STEM CELLS

ESTIMATED TOTAL FUNDS REFER TO THE FUNDS AVAILABLE FOR CASH GRANTS WHILE ESTIMATED NUMBER OF GRANTS EQUALS TOTAL OF ALL AMERICORPS VISTA PROJECTS, TH

ADVANCES IN PLASMODIUM VIVAX MALARIA RESEARCH

4TH ANNUAL MEETING OF THE OLIGONUCLEOTIDE THERAPEUTICS SOCIETY

FOURTH ANNUAL SYMPOSIUM ON NEPHROGENIC SYSTEMIC FIBROSIS AND GADOLINIUM BASED CON

TARGETING VEGF-MEDIATED TUMOR ANGIOGENESIS IN CANCER THERAPY

PROBIOTICS: BENCH TO MARKET